SPIA
NXTM

Steward Partners Investment Advisory’s NxStage Medical Inc. NXTM Stock Holding History

Steward Partners Investment Advisory’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,000
Closed -$139K – 2548
2018
Q3 		$139K Sell
5,000
-700
-12% -$19.7K 0.01% 820
2018
Q2 		$159K Buy
5,700
+5,000
+714% +$134K 0.01% 714
2018
Q1 		$17K Sell
700
-100
-13% -$2.43K ﹤0.01% 1411
2017
Q4 		$19K Buy
+800
New +$21.1K ﹤0.01% 1143

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steward Partners Investment Advisory's NXTM Position: Q4 2018 in Review

Steward Partners Investment Advisory sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 5,000 shares — an estimated $139K sold.

Steward Partners Investment Advisory first reported a position in NXTM in Q4 2017 and held it in 4 quarters. The position peaked at $159K in Q2 2018. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

  • Steward Partners Investment Advisory reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 5,000 NxStage Medical Inc. shares in Q4 2018, an estimated $139K.
  • Steward Partners Investment Advisory first reported a position in NxStage Medical Inc. in Q4 2017 and held it in 4 quarters.
  • Steward Partners Investment Advisory's NxStage Medical Inc. position peaked at $159K in Q2 2018.
  • 172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2018, filed 15 Jan 2019.